Jazz Pharmaceuticals Director Ted W. Love Reports Tax Withholding Disposition
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing: Jazz Pharmaceuticals plc ($JAZZ)
Insider: Ted W. Love (Director)
Transaction: Tax Withholding Disposition (Code F)
Details: 743 Ordinary Shares disposed at weighted avg $241.41 ($179,368.74 total) to cover tax withholding upon RSU vesting.
Post-Transaction Holdings: 2,389 shares (Direct)
Significance: Low (Routine tax obligation fulfillment)
Comprehensive Analysis
Insider Transaction Summary
- Insider: Ted W. Love (Director)
- Issuer: Jazz Pharmaceuticals plc ($JAZZ)
- Transaction Date: August 31, 2026
- Filing Date: September 2, 2026
- Transaction Type: Code F (Shares withheld/sold to satisfy tax obligations upon RSU vesting)
- Total Shares Withheld/Sold: 743 Ordinary Shares across two tranches:
- 6 shares @ $244.0633 ($1,464.38)
- 737 shares @ $241.3899 ($177,904.36)
- Total Transaction Value: $179,368.74
- Remaining Holdings: 2,389 Ordinary Shares (Direct ownership)
Analytical Takeaway
This filing reflects a standard, non-discretionary tax withholding transaction (Code F) to cover tax liabilities associated with the vesting of restricted stock units (RSUs). Because this was not an open-market discretionary sale, it holds low informational signal for market participants.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.